A major discovery in cancer study is emerging with the use of VHH fragments to re-engage dysfunctional p53. This vital malignant inhibitor protein is frequently lost in various forms of malignancies, causing https://total-bookmark.com/story21795398/mini-antibodies-reactivate-tumor-suppressor-p53-new-potential-approach-for-malignant-therapy